{
    "clinical_study": {
        "@rank": "138123", 
        "brief_summary": {
            "textblock": "This study examines the use of insulin-sensitizing compounds, as therapeutic agents for\n      cognitive impairment in Alzheimer's disease."
        }, 
        "brief_title": "Insulin, Neurogenetics and Memory in Alzheimer's Disease", 
        "completion_date": "March 2003", 
        "condition": "Alzheimer Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Men and women with mild Alzheimer's Disease without serious medical or psychiatric\n        comorbid conditions."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "55 Years"
        }, 
        "firstreceived_date": "July 3, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00018382", 
            "org_study_id": "AGCG-012-98S"
        }, 
        "intervention": {
            "intervention_name": "rosiglitazone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Rosiglitazone"
        }, 
        "lastchanged_date": "January 20, 2009", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seattle", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98108"
                }, 
                "name": "VA Puget Sound Health Care System"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach", 
        "overall_official": [
            {
                "last_name": "Steven Kahn, M.D."
            }, 
            {
                "last_name": "Sanjay Asthana, M.D."
            }, 
            {
                "last_name": "Alfred Fujimoto, M.D."
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00018382"
        }, 
        "source": "Department of Veterans Affairs", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "October 1999", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2004"
    }, 
    "geocoordinates": {
        "VA Puget Sound Health Care System": "47.606 -122.332"
    }
}